|
2006
Conference
Programme
1.
The Genetics Revolution
2.
Population and Health: What will be the nature and funding of
healthcare in an aging society?
1.
The Genetics Revolution
(In
Partnership with the Stifterverband
für die Deutsche Wissenschaft, the Deutsche
Forschungsgemeinschaft, the Wellcome Trust and the UK Foreign and Commonwealth
Office)
Wellcome
Trust Conference Centre, nr. Cambridge
20-26 August 2006
Recent
advances in genetic science – human, animal and plant – have been
dramatic in recent years, and more are promised for the coming decades,
which are likely to be among the key developments of the 21st century.
It is time to review both the science and the debates which surround it
about how we best establish ethical boundaries while nurturing
creativity in research and application, and, in the light of this,
assess how well we are setting the direction of public policy in Europe
and the world at large, and developing the relationship between science
and society. Topics will include: what can realistically be
expected from genetic science in the coming decade; the ongoing debates
which link ethics, risk and benefit (such as stem-cell research,
cloning, the use of GM crops, xenotransplantation, and the enhancement
of animals or even humans); how public engagement, governance, and
accountability in these areas can best be improved and structured;
issues of the ownership of individual and population genetic
information, and the proper balance between its use and the privacy of
individuals; as well as how best to encourage dynamic, responsible
research, whether public or private, addressing needs both at the
national and global level.
Senior
Fellow:
Professor Martin Bobrow, University
of Cambridge
Back to Top
2.
Population and Health:
what will be the nature and funding of healthcare in an aging society?
(In Partnership
with the Stifterverband
für die Deutsche Wissenschaft, the Deutsche
Forschungsgemeinschaft, the
UK Foreign and
Commonwealth Office, and
the Max Planck
Institute for Demographic Research, Rostock)
Max Planck
Institute for Demographic Research, Rostock
Dates to be announced
Apply
to Attend
Countries
everywhere except for Sub-Saharan Africa will have older populations in
the near future, with the world’s percentage of those over 65 rising
from 6.9% to 12% by 2030. Japan and Europe are already
starting to see this trend: developing parts of Asia will, if anything,
experience it to an even greater degree. This shift is of key
importance for a host of political, economic, and social
issues.
One central concern will be health care, already undergoing technology
and cost induced upheavals of its own. Issues at the
interface of changes in demography and health care include: the likely
degree and nature of the demographic shift, involving political
questions such as immigration; the real impact of this shift as older
individuals may well be ever healthier in the future and behave more
like younger ones; the effect on provision, research priorities, and
populations themselves of the changing disease load, particularly the
shift to chronic care brought about by aging, but also by increased
wealth and environmental factors such as global warming. Added to these
questions are the growing demands from ever better informed patients
who are expanding what they expect from doctors. The issue of knowledge
points up the need for social as well as medical and scientific
responses to these upheavals, given the inverse correlation at the
individual level between educational attainment and need for medical
resources in old age. And changes in social assumptions and
attitudes in connection with aging, as well as new technologies, are
expanding the boundaries of medicine itself, with cosmetic surgery and
pharmacological interventions in developed countries making it a
technology to ‘stay young’.
With population change, technological advance, and changes in social
norms, medical costs are rocketing, and this has a considerable impact
on the roles of public and private sectors both in developed countries
and in fast-developing ones, which are likely to see rapid and
controversial expansion of the latter. As well as the challenge of
funding, there is the problem of finding enough trained medical
personnel, as they like all others experience aging cohorts, and there
are the practical and ethical issues of health services in developed
countries attracting ever greater numbers from the developing world.
Finally, many present assumptions may have to be revised, given newly
emerging diseases. This has already been the case with regard
to HIV/AIDS, and not just in sub-Saharan Africa, and avian flu may yet
make its mark on population profiles around the world.
This conference will use a scenario-building approach to map the
uncertainties ahead. Different approaches to public policy
making in this area will be assessed, along with public engagement with
the medical science and the politics which will affect people’s fates
on through the 21st century as individuals, cohorts and whole societies.
Senior
Fellow:
To be confirmed
Back to Top
|